BioPharma Resources

Drug Trial Radar · NCT06377930

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

A Phase 2A, Multicenter, Open-label Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Last checked: Nov 19, 2026Latest source record: Feb 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Oct 10, 2024

Primary completion

Sep 26, 2025

Study completion Sep 26, 2025

Sponsor

Lead sponsor
Rapport Therapeutics Inc.Industry
Sponsor type
Industry
First posted
Apr 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine if RAP-219 works and is safe in patients with Refractory Focal Epilepsy.

Conditions

  • Focal Onset Seizures

Interventions

  • RAP-219Drug

    RAP-219 oral tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in long episode frequency during the treatment period compared to pre-treatment baseline: Responder proportion, Percent Change Percent changeTime frame: Screening until 5 months after enrollment

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Yale University

    New Haven, Connecticut

  • Consultants in Epilepsy and Neurology, PLLC

    Boise, Idaho

  • IU Health Neuroscience Center, Goodman Hall

    Indianapolis, Indiana

  • The University of Kansas Medical Center Epilepsy Clinic

    Kansas City, Kansas

  • Mayo Clinic

    Rochester, Minnesota

  • NYU Langone Comprehensive Epilepsy Center

    New York, New York

  • Cleveland Clinic Foundation

    Cleveland, Ohio

  • University of Pennsylvania - Department of Neurology

    Philadelphia, Pennsylvania

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Baylor College of Medicine

    Houston, Texas

  • University of Texas Health Science Center, Houston

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.